- Global Pharma News & Resources

Oncology Drugs have become far more sophisticated and efficient in treating different types of cancer with minimum side effects to the patient

Oncology Drugs have become far more sophisticated and efficient in treating different types of cancer with minimum side effects to the patient


Oncology is the study of cancer treatments that extend beyond the normal curative scope. The primary focus is localized disease management through the delivery of targeted therapy to treat cancerous sites.
  • Author Name: M. Clark
Editor: Soumya Mohanty Last Updated: 23-Jun-2021

North America is home to many pharmaceutical companies that are pursuing research into the management of diseases such as prostate and breast cancer and skin cancer. One of the major segments gaining popularity with oncology drugs is the lung-cancer drugs. A number of promising lung cancers have been found to respond to the effects of oncology drugs in the test groups. The first such drug, Cisplatin, was tested in patients suffering from adenocarcinoma of the lung. It significantly prolonged survival time in these patients. The next drug in the line, Sawatagel, was also successful in treating patients with stage I and II breast cancer. Results of further studies are expected soon.

Chemotherapy is one of the common procedures in the treatment of cancer. Cancer patients use a series of medications for this therapy. The medicines are administered through intravenous methods or oral methods. This procedure is very effective as it targets the tumor and kills the cancerous cells. However, this procedure has a very high cost as the drugs have to be procured from the pharmaceutical companies at a very high cost.

Cost-sharing or the reimbursement program allows the cost of Oncology drugs to be shared by the patients. It is one of the best ways for hospitals to cut down the cost of treatments. The concept of cost-sharing per quality-adjustment life-year was introduced by the government to lessen the financial burden of the health care system. It allows hospitals to share the total cost of the treatment for all patients within a five-year period based on their Medicare schedule. There are also several Oncology specialty drugs that can target the disease process, thus preventing the recurrence of the disease after surgery. The use of drugs such as tamoxifen, fluridil, and methotrexate has been shown to lead to an increased survival rate in women with breast cancer. Patients who take these drugs have a greater ability to tolerate anesthesia and chemotherapy. Furthermore, the drugs help to increase the elasticity of tissues. Patients who undergo this therapy often have a greater ability to withstand major surgeries and recover faster from other injuries.

As medical technology advances, Oncology drugs become essential components of the patient's overall health plan. For instance, Tamoxifen must be included in any health economics model that attempts to assess the value of life during and after cancer treatment. Similarly, patients who do not take Tamoxifen or who choose alternative treatments may not obtain the full benefits of the drug. As new Oncology specialty drugs are developed, it becomes increasingly important for hospitals to incorporate these into their overall cost-effectiveness strategies. Google Scholars is a great way for Oncology professionals to gain insight into the latest oncology drugs and their potential uses in cancer therapy.

More details: